Prairiewood Capital, LLC Co Diagnostics, Inc. Transaction History

Prairiewood Capital, LLC

  • $233 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022
SELL
$5.03 - $9.61 $2,147 - $4,103
-427 Reduced 0.72%
59,145 $366,000
Q4 2021

Jan 20, 2022
BUY
$8.12 - $10.37 $1,745 - $2,229
215 Added 0.36%
59,572 $532,000
Q3 2021

Oct 13, 2021
BUY
$7.48 - $11.38 $443,990 - $675,482
59,357 New
59,357 $578,000

Others Institutions Holding CODX

# of Institutions
45
Shares Held
5.59M
Call Options Held
67.5K
Put Options Held
174K
View Full List

About Co-Diagnostics, Inc.

CODX Quotes by TradingView
  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $15.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Prairiewood Capital, LLC Portfolio

Follow Prairiewood Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairiewood Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email